Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
The research suggests that patients with cancer who previously received preventative prescriptions even without pain may now be less likely to receive a prescription until they begin reporting pain.
Hematology/Oncology November 17th 2025
Oncology News Central (ONC)
“Subcutaneous administration offers substantial workflow advantages. It can decrease chair time, reduce dependency on central lines, and allow for faster patient turnover.” – Dr. Aakash Desai
Hematology/Oncology October 8th 2025
Epoch Health
Multiple oncologists report anecdotal success with antiparasitic protocols, citing at least 12 potential anticancer mechanisms while acknowledging the absence of human clinical trials and FDA approval for cancer treatment.
Hematology/Oncology July 22nd 2025
Hematology Advisor
Final analysis confirms venetoclax plus modified intensive chemotherapy achieves durable remissions with 17.9-month treatment-free intervals in fit elderly AML patients, particularly those with de novo disease.
Clinical Pharmacology July 22nd 2025
Nature exposure demonstrates measurable psychological benefits for cancer patients, including reduced anxiety and improved quality of life, though direct immune system claims require further clinical validation.
Hematology/Oncology May 27th 2025
Healthline
Five-year survival rates for chronic lymphocytic leukemia show promising outcomes even in elderly patients, with 77% survival in those 75 and older.
Geriatrics December 5th 2024